Gips Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 16-07-2024
- Paid Up Capital ₹ 5.00 M
as on 16-07-2024
- Company Age 12 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 123.00 M
as on 16-07-2024
- Revenue 58.50%
(FY 2021)
- Profit 61.59%
(FY 2021)
- Ebitda 134.56%
(FY 2021)
- Net Worth 25.63%
(FY 2021)
- Total Assets 14.21%
(FY 2021)
About Gips Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹12.30 Cr.
Rajesh Maniar, Pradeep Vaghasiya, Himanshu Desai, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85190GJ2012PTC071988
- Company No.
071988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Gips Hospital?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Maniar  | Director | 17-Sep-2012 | Current |
| Pradeep Vaghasiya | Director | 17-Sep-2012 | Current |
| Himanshu Desai | Director | 17-Sep-2012 | Current |
| Dharmesh Vishnubhai | Director | 17-Sep-2012 | Current |
| Suhas Doshi | Director | 17-Sep-2012 | Current |
Financial Performance and Corporate Structure Insights of Gips Hospital.
Gips Hospital Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 58.5% increase. The company also saw a substantial improvement in profitability, with a 61.59% increase in profit. The company's net worth Soared by an impressive increase of 25.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gips Hospital?
In 2021, Gips Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Serotonin Pharmaceuticals Llp
Active
6 years 9 months Pradeep Vaghasiya and Himanshu Desai are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 11 Nov 2020 | ₹5.00 M | Open |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 25 Oct 2019 | ₹9.00 Cr | Open |
The Kalupur Comm. Co Op. Bank Ltd Creation Date: 22 Aug 2014 | ₹2.80 Cr | Open |
How Many Employees Work at Gips Hospital?
Gips Hospital has a workforce of 39 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Aug 29, 2014, Gips Hospital has raised a total of ₹ 4.9 M, with the most recent deal valued at ₹ 4.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
